Diagnosis and Treatment of Systemic Juvenile Idiopathic Arthritis (sJIA) in Pediatric Age Groups

AAP

American Academy of Pediatrics

ACR

American College of Rheumatology

AOSD

Adult-onset Still’s disease

CD

Cluster of Differentiation

CPG

Clinical Practice Guideline

CPS

Canadian Pediatric Society

DMARDs

Disease-modifying antirheumatic drugs

cDMARDs

Conventional Disease-modifying antirheumatic drugs

EPG

Egyptian Pediatric Clinical Practice Guidelines Committee

EULAR

European League against Rheumatism

GAG

Guideline Adaptation Group

GIN

Guidelines International Network

GKJR

German Society for Pediatric Rheumatology

GRADE

Grading of Recommendations, Assessment, Development and Evaluation

ILAR

International League of Associations for Rheumatology

IVIG

Intravenous Immunoglobulin

JADAS

Juvenile Arthritis Disease Activity Score

JAK

Janus kinase

MAS

Macrophage activation syndrome

MOH

Ministry of Health

MRI

Magnetic Resonance Imaging

mSMS

Modified systemic manifestation score

NICE

National Institute for Health and Care Excellence

NK

Natural Killer

PET-CT

Positron Emission Tomography

PRINTO

Pediatric Rheumatology International Trials Organization

QoE

Quality of Evidence

SIGN

The Scottish Intercollegiate Guidelines Network

sJIA

Systemic Juvenile Idiopathic Arthritis

SoR

Strength of Recommendations